Genetic Technologies Ltd (GTG) - Financial and Strategic SWOT Analysis Review

October 2021 | 59 pages | ID: G520AD274D7EN
GlobalData

Abstracts

Genetic Technologies Ltd (GTG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genetic Technologies Ltd (GTG) is a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment. It delivers the offerings by GeneType for breast cancer tests and GeneType test for colorectal cancer. GeneType for breast cancer, a test that examines woman’s clinical risk factors with scientifically validated genetic biomarkers, to enable personalized breast cancer risk assessment and GeneType for Colorectal Cancer combines patient age, genetic markers and family history to provide a more accurate assessment of colorectal cancer risk. The company serves healthcare providers and patients in the US and Australia. GTG is headquartered in Fitzroy, Victoria, Australia.

Genetic Technologies Ltd Key Recent Developments

Aug 31,2021: Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy
Jul 09,2021: Genetic Technologies continues to break new ground as it advances development of its predictive risk test for multiple cancers & morbidities
Jun 11,2021: US Patent Office grants foundational pharmacogenomic patent
Apr 12,2021: Genetic Technologies appoints Mike Tonroe as CFO
Jan 04,2021: Genetic Technologies appoints Simon Morriss as CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Genetic Technologies Ltd - Key Facts
Genetic Technologies Ltd - Key Employees
Genetic Technologies Ltd - Key Employee Biographies
Genetic Technologies Ltd - Major Products and Services
Genetic Technologies Ltd - History
Genetic Technologies Ltd - Company Statement
Genetic Technologies Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Genetic Technologies Ltd - Business Description
Geographical Segment: Australia
Performance
Geographical Segment: The US
Performance
R&D Overview
Genetic Technologies Ltd - Corporate Strategy
Genetic Technologies Ltd - SWOT Analysis
SWOT Analysis - Overview
Genetic Technologies Ltd - Strengths
Genetic Technologies Ltd - Weaknesses
Genetic Technologies Ltd - Opportunities
Genetic Technologies Ltd - Threats
Genetic Technologies Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Genetic Technologies Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 31, 2021: Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy
Jul 09, 2021: Genetic Technologies continues to break new ground as it advances development of its predictive risk test for multiple cancers & morbidities
Jun 11, 2021: US Patent Office grants foundational pharmacogenomic patent
Apr 12, 2021: Genetic Technologies appoints Mike Tonroe as CFO
Jan 04, 2021: Genetic Technologies appoints Simon Morriss as CEO
Oct 30, 2020: Genetic Technologies : Quarterly activities report for the quarter ended 30 September 2020
Apr 17, 2020: COVID-19 testing capacity at Genetic Technologies accredited laboratory
Apr 01, 2020: Genetic Technologies announces market update on sales, early test results and launch of consumer initiated testing
Jan 31, 2020: Genetic Technologies: Quarterly report

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Genetic Technologies Ltd, Key Facts
Genetic Technologies Ltd, Key Employees
Genetic Technologies Ltd, Key Employee Biographies
Genetic Technologies Ltd, Major Products and Services
Genetic Technologies Ltd, History
Genetic Technologies Ltd, Subsidiaries
Genetic Technologies Ltd, Key Competitors
Genetic Technologies Ltd, Ratios based on current share price
Genetic Technologies Ltd, Annual Ratios
Genetic Technologies Ltd, Annual Ratios (Cont...1)
Genetic Technologies Ltd, Interim Ratios
Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Genetic Technologies Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Genetic Technologies Ltd, Performance Chart (2017 - 2021)
Genetic Technologies Ltd, Ratio Charts
Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021